Biostasis Newsletter February 2024
Cryonics Revival Preferences, Changing Mainstream Views on Death, and Upcoming Events
Revival Preference Enforcement
Some proactive cryonicists have executed specific revival preference with their cryopreservation paperwork. Should these preferences be treated as good-practice guidelines? Are they enforceable? What if someone executes revival preferences that are known to be based on dated knowledge at the time of revival? In his article, Max More gives many examples of such revival preferences and the ethical and practical challenges they can present.
The Ghost in the Machine
Modern medicine does rest on the premise that the brain is the mind, but recognition that death is a process, and that cessation of metabolism (or even change of structure) does not necessarily entails death, remains an uphill battle. Brian Wowk reviews some recent Newsweek coverage that moves our understanding of death closer to what we think in cryonics but also identifies some persistent misunderstandings and poor phrasing on these issues.
Global Cryonics Summit
On July 20-21, thought leaders in cryonics will gather for the Global Cryonics Summit in Miami Florida. Speakers include Biostasis Technologies President Aschwin de Wolf, Biostasis Technologies Director of Communications Max More, and Director of Clinical Education at Resurgence Biomedical Sciences, Aaron Drake.
Save the Date!
On October 11-13 several Biostasis Technologies staff members will be presenting at the 2024 Tomorrow Biostasis event in Zurich, Switzerland. If you want to attend a cryonics conference at the premises of a new European cryonics storage facility, this is the event for you. We expect major announcements to be made at this meeting.
Biostasis Standard Subscriptions
Our aim for 2024 is to end the year with at least 1,000 subscribers. Please take some time to think of any family, friends, or colleagues who are interested in the field of human biostasis and send them to our website. Or share our finest articles on social media. We also hope that some of you will turn your current subscription into a paid subscription. Paid subscribers can comment on articles and will get access to early and exclusive content.